Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme

Overview of attention for article published in Diabetologia, August 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 2 news outlets
policy: 1 policy source
twitter: 50 X users

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 182 Mendeley

So far, Altmetric has seen 64 X posts from 50 X users, with an upper bound of 285,282 followers.

"Incorporating lifetime healthcare cost savings due to periods of remission from diabetes and its complications, the DiRECT intervention is predicted to be both more effective and cost-saving in adults with type 2 diabetes compared with standard care." …

@LeenaPutkonen @AittolaKirsikka Ja tästä tosiaan on myös kustannusvaikuttavuuslaskelmiakin jo julkaistu: https://t.co/04vxm52stK

RT @DocRunner1: 9/9 References: A huge thank you to @zoeharcombe (see also https://t.co/5u4TK5knta ) for her help and hard work making sen…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 60 additional X posts.